These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 8380670)

  • 1. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome.
    Sedarati F; Margolis TP; Stevens JG
    Virology; 1993 Feb; 192(2):687-91. PubMed ID: 8380670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and molecular aspects on herpes simplex virus latency.
    Lycke E
    Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs.
    Margolis TP; Bloom DC; Dobson AT; Feldman LT; Stevens JG
    Virology; 1993 Dec; 197(2):585-92. PubMed ID: 8249281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered properties of the herpes simplex virus ICP8 DNA-binding protein in cells infected with ICP27 mutant viruses.
    Curtin KD; Knipe DM
    Virology; 1993 Sep; 196(1):1-14. PubMed ID: 8395110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes.
    Gesser RM; Valyi-Nagy T; Fraser NW
    Virology; 1994 May; 200(2):791-5. PubMed ID: 8178461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
    Huard J; Goins WF; Glorioso JC
    Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers.
    Block TM; Deshmane S; Masonis J; Maggioncalda J; Valyi-Nagi T; Fraser NW
    Virology; 1993 Feb; 192(2):618-30. PubMed ID: 8380666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia.
    Valyi-Nagy T; Deshmane SL; Spivack JG; Steiner I; Ace CI; Preston CM; Fraser NW
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():641-9. PubMed ID: 1848599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
    Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
    J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of viral and cellular gene expression in sensory neurons.
    Latchman DS
    Gene Ther; 1994; 1 Suppl 1():S25-7. PubMed ID: 8542388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
    Mukerjee R; Kang W; Suri V; Fraser NW
    Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
    Chen YM; Knipe DM
    Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice.
    Nishiyama Y; Kurachi R; Daikoku T; Umene K
    Virology; 1993 May; 194(1):419-23. PubMed ID: 8386887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus vectors and gene transfer to brain.
    Glorioso JC; Goins WF; Fink DJ; DeLuca NA
    Dev Biol Stand; 1994; 82():79-87. PubMed ID: 7958486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
    Mester JC; Pitha PM; Glorioso JC
    Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
    O'Brien WJ; Tsao LS; Taylor JL
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG; Krisky DM; Ataai MM; Glorioso JC
    Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
    Jean S; LeVan KM; Song B; Levine M; Knipe DM
    Virology; 2001 May; 283(2):273-84. PubMed ID: 11336552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular biology of pathogenesis by herpesvirus].
    Barrón BL; Vales N
    Rev Latinoam Microbiol; 1991; 33(1):77-85. PubMed ID: 1670258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.